Statements of Cash Flows - USD ($)	5 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021
Cash flows from operating activities:
Net income (loss)	$ (1,272)	$ 4,587,621
Interest earned on marketable securities held in Trust Account		(32,632)
Offering costs allocated to warrants		438,287
Change in fair value of warrant liability		(7,549,843)
Offering costs allocated to warrants	448
Changes in operating assets and liabilities:
Prepaid expense		(63,613)
Accrued expenses		321,049
Due to related party		117,223
Net cash used in operating activities	(824)	(2,181,908)
Cash Flows from Investing Activities:
Investment of cash in Trust Account		(151,742,500)
Net cash used in investing activities		(151,742,500)
Cash Flows from Financing Activities:
Proceeds from issuance of founder shares	25,000
Proceeds from sale of Units, net of underwriting discount		146,510,000
Proceeds from issuance of Private Placement Warrants		7,057,500
Proceeds from promissory note – related party	141,451	1,010,800
Repayment of promissory note – related party		(152,251)
Payment of offering costs	(165,593)	(307,641)
Net cash provided by financing activities	858	154,118,408
Net change in cash	34	194,000
Cash, beginning of period		34
Cash, end of the period	34	194,034
Supplemental disclosure of cash flow information:
Deferred offering costs included in accrued offering costs and expenses	9,785
Deferred underwriting commissions payable charged to additional paid in capital		$ 5,232,500